BCR and pachyonychia congenita: By revealing the spatial distribution of the clinical features of specific levels along with the combination of the stratum and BCR status, the CA fully described the overall characteristics of the individual subgroups of PC patients with a molecular predisposition to BCR-anticipated progression.